The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
Open accessAbstract
BACKGROUND: Many mathematical models have investigated the impact of expanding access to antiretroviral therapy (ART) on new HIV infections. Comparing results and conclusions across models is challenging because models have addressed slightly different questions and have reported different outcome metrics. This study compares the predictions of several mathematical models simulating the same ART intervention programmes to determine the extent to which models agree about the epidemiological impact of expanded ART. METHODS AND FINDINGS: Twelve independent mathematical models evaluated a set of standardised ART intervention scenarios in South Africa and reported a common set of outputs. Intervention scenarios systematically varied the CD4 count threshold for treatment eligibility, access to treatment, and programme retention. For a scenario in which 80% of HIV-infected individuals start treatment on average 1 y after their CD4 count drops below 350 cells/µl and 85% remain on treatment after 3 y, the models projected that HIV incidence would be 35% to 54% lower 8 y after the introduction of ART, compared to a counterfactual scenario in which there is no ART. More variation existed in the estimated long-term (38 y) reductions in incidence. The impact of optimistic interventions including immediate ART initiation varied widely across models, maintaining substantial uncertainty about the theoretical prospect for elimination of HIV from the population using ART alone over the next four decades. The number of person-years of ART per infection averted over 8 y ranged between 5.8 and 18.7. Considering the actual scale-up of ART in South Africa, seven models estimated that current HIV incidence is 17% to 32% lower than it would have been in the absence of ART. Differences between model assumptions about CD4 decline and HIV transmissibility over the course of infection explained only a modest amount of the variation in model results. CONCLUSIONS: Mathematical models evaluating the impact of ART vary substantially in structure, complexity, and parameter choices, but all suggest that ART, at high levels of access and with high adherence, has the potential to substantially reduce new HIV infections. There was broad agreement regarding the short-term epidemiologic impact of ambitious treatment scale-up, but more variation in longer term projections and in the efficiency with which treatment can reduce new infections. Differences between model predictions could not be explained by differences in model structure or parameterization that were hypothesized to affect intervention impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Self-citationRates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Attia, S., Egger, M., Müller, M., Zwahlen, M., & Low, N. (2009) · AIDS · doi:10.1097/qad.0b013e32832b7dca · Cited by 1,001
Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 952
Boily, M.-C., Baggaley, R. F., Wang, L., Masse, B., White, R. G., Hayes, R. J., & Alary, M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70021-0 · Cited by 913
Shisana, O., Rehle, T. M., Simbayi, L. C., Zuma, K. K., Jooste, S., Wyk, V. P., Mbelle, N. M., van Zyl, J., Parker, W., Zungu, N. P., et al. (2009) · Cited by 790
Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review
Rosen, S., & Fox, M. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001056 · Cited by 738
Modeling targeted layered containment of an influenza pandemic in the United States
Halloran, M. E., Ferguson, N. M., Eubank, S., Longini, I. M., Cummings, D. A. T., Lewis, B., Xu, S., Fraser, C., Vullikanti, A., Germann, T. C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706849105 · Cited by 662
Self-citationHIV-1 Transmission, by Stage of Infection
Hollingsworth, T. D., Anderson, R. M., & Fraser, C. (2008) · The Journal of Infectious Diseases · doi:10.1086/590501 · Cited by 652
Self-citationMontaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69162-9 · Cited by 555
Towards an improved investment approach for an effective response to HIV/AIDS
Schwartländer, B., Stover, J., Hallett, T., Atun, R., Avila, C., Gouws, E., Bartos, M., Ghys, P. D., Opuni, M., Barr, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60702-2 · Cited by 523
Self-citationBunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., Coutinho, A., Liechty, C., Madraa, E., Rutherford, G., et al. (2006) · AIDS · doi:10.1097/01.aids.0000196566.40702.28 · Cited by 463
Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
Fraser, C., Hollingsworth, T. D., Chapman, R., de Wolf, F., & Hanage, W. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708559104 · Cited by 438
Self-citationCohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey
Tanser, F., Hosegood, V., Barnighausen, T., Herbst, K., Nyirenda, M., Muhwava, W., Newell, C., Viljoen, J., Mutevedzi, T., & Newell, M.-L. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym211 · Cited by 402
A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco
Blower, S. M., Gershengorn, H. B., & Grant, R. M. (2000) · Science · doi:10.1126/science.287.5453.650 · Cited by 390
Powers, K. A., Ghani, A. C., Miller, W. C., Hoffman, I. F., Pettifor, A. E., Kamanga, G., Martinson, F. E., & Cohen, M. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60842-8 · Cited by 312
Barth, R. E., van der Loeff, M. F. S., Schuurman, R., Hoepelman, A. I., & Wensing, A. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70328-7 · Cited by 310
VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
Uinn, T. H. C. Q., Awer, M. A. J. W., Ewankambo, N. E. S., Erwadda, D. A. S., Eehan, M. A. O. M., Utalo, T. H. L., Onald, R., Ray, H. G., Roject, A. P., & Roup, S. T. G. (2011) · Cited by 305
京都大学グローバルCOEプログラムアジア・メガシティの人間安全保障工学拠点 (2010) · Medical Entomology and Zoology · Cited by 282
Vernazza, P. L., Troiani, L., Flepp, M. J., Cone, R. W., Schock, J., Roth, F., Boggian, K., Cohen, M. S., Fiscus, S. A., & Eron, J. J. (2000) · AIDS · doi:10.1097/00002030-200001280-00006 · Cited by 271
Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings
Dodd, P. J., Garnett, G. P., & Hallett, T. B. (2010) · AIDS · doi:10.1097/qad.0b013e32833433fe · Cited by 268
Self-citationBoulle, A., Van Cutsem, G., Hilderbrand, K., Cragg, C., Abrahams, M., Mathee, S., Ford, N., Knight, L., Osler, M., Myers, J., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328333bfb7 · Cited by 264
Cornell, M., Grimsrud, A., Fairall, L., Fox, M. P., van Cutsem, G., Giddy, J., Wood, R., Prozesky, H., Mohapi, L., Graber, C., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833d45c5 · Cited by 223
Access to antiretroviral treatment in South Africa, 2004 - 2011
Johnson, L. F. (2012) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v13i1.156 · Cited by 213
Self-citationCould widespread use of combination antiretroviral therapy eradicate HIV epidemics?
Velasco-Hernandez, J., Gershengorn, H., & Blower, S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00346-8 · Cited by 199
Reynolds, S. J., Makumbi, F., Nakigozi, G., Kagaayi, J., Gray, R. H., Wawer, M., Quinn, T. C., & Serwadda, D. (2011) · AIDS · doi:10.1097/qad.0b013e3283437c2b · Cited by 189
Nash, D., Katyal, M., Brinkhof, M. W., Keiser, O., May, M., Hughes, R., Dabis, F., Wood, R., Sprinz, E., Schechter, M., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3283121ca9 · Cited by 182
Long, E. F., Brandeau, M. L., & Owens, D. K. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00004 · Cited by 180
Self-citationBezemer, D., de Wolf, F., Boerlijst, M. C., van Sighem, A., Hollingsworth, T. D., Prins, M., Geskus, R. B., Gras, L., Coutinho, R. A., & Fraser, C. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd167c · Cited by 173
Self-citationEffect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
Cu-Uvin, S., Caliendo, A. M., Reinert, S., Chang, A., Juliano-Remollino, C., Flanigan, T. P., Mayer, K. H., & Carpenter, C. C. J. (2000) · AIDS · doi:10.1097/00002030-200003100-00015 · Cited by 172
Modelling the Impact of Antiretroviral Use in Resource-Poor Settings
Baggaley, R. F., Garnett, G. P., & Ferguson, N. M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030124 · Cited by 168
Blower, S., Bodine, E., Kahn, J., & McFarland, W. (2005) · AIDS · doi:10.1097/00002030-200501030-00001 · Cited by 161
UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000109 · Cited by 158
Gender and Access to Antiretroviral Treatment in South Africa
Nattrass, N. (2008) · Feminist Economics · doi:10.1080/13545700802266452 · Cited by 156
Gray, R. H., Li, X., Wawer, M. J., Gange, S. J., Serwadda, D., Sewankambo, N. K., Moore, R. D., Wabwire‐Mangen, F., Lutalo, T., & Quinn, T. C. (2003) · AIDS · doi:10.1097/00002030-200309050-00013 · Cited by 148
Wilson, D. P. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001231 · Cited by 131
Xiridou, M., Geskus, R. B., de Wit, J. B. F., Coutinho, R. A., & Kretzschmar, M. (2003) · AIDS · doi:10.1097/00002030-200305020-00012 · Cited by 127
Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1
Anderson, R. M., Gupta, S., & May, R. M. (1991) · Nature · doi:10.1038/350356a0 · Cited by 117
Cohen, M. S., Dye, C., Fraser, C., Miller, W. C., Powers, K. A., & Williams, B. G. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001232 · Cited by 103
Self-citationAntiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
Granich, R., Gupta, S., Suthar, A. B., Smyth, C., Hoos, D., Vitória, M., Simão, M. B. G., Hankins, C. A., Schwartländer, B., Ridzon, R., et al. (2011) · Current HIV Research · doi:10.2174/157016211798038597 · Cited by 99
Self-citationCan antiretroviral therapy eliminate HIV transmission?
Cock, K. M. D., Gilks, C. F., Lo, Y.-R. J., & Guerma, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61732-8 · Cited by 98
Johnson, L. F., Hallett, T. B., Rehle, T. M., & Dorrington, R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0826 · Cited by 97
Self-citationThe epidemiological impact of antiretroviral use predicted by mathematical models: a review
Baggaley, R. F., Ferguson, N. M., & Garnett, G. P. (2005) · Emerging Themes in Epidemiology · doi:10.1186/1742-7622-2-9 · Cited by 92
Ageing with HIV in South Africa
Hontelez, J. A. C., Lurie, M. N., Newell, M., Bakker, R., Tanser, F. C., Bärnighausen, T., Baltussen, R. M. P. M., & de Vlas, S. J. (2011) · AIDS · doi:10.1097/qad.0b013e32834982ea · Cited by 89
Self-citationJohnson, L., Dorrington, R., Bradshaw, D., Wyk, V. P., & Rehle, T. M. (2009) · Demographic Research · doi:10.4054/demres.2009.21.11 · Cited by 86
Self-citationPhillips, A. N., Pillay, D., Garnett, G. P., Bennett, D., Vitória, M., Cambiano, V., & Lundgren, J. D. (2010) · AIDS · doi:10.1097/qad.0b013e328344037a · Cited by 85
Self-citationStover, J., Johnson, P., Hallett, T. B., Marston, M., Becquet, R., & Timæus, I. M. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2010.044222 · Cited by 84
Self-citationDangerfield, B. C., Fang, Y., & Roberts, C. A. (2001) · System Dynamics Review · doi:10.1002/sdr.211 · Cited by 83
Eisele, T. P., Mathews, C., Chopra, M., Lurie, M. N., Brown, L. F., Dewing, S., & Kendall, C. (2008) · AIDS and Behavior · doi:10.1007/s10461-008-9473-2 · Cited by 82
Althaus, C. L., Turner, K., Schmid, B. V., Heijne, J. C. M., Kretzschmar, M., & Low, N. N. (2011) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0131 · Cited by 77
HIV Treatment as Prevention: Models, Data, and Questions—Towards Evidence-Based Decision-Making
The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001259 · Cited by 76
Comparative Effectiveness of HIV Testing and Treatment in Highly Endemic Regions
Bendavid, E., Brandeau, M. L., Wood, R., & Owens, D. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.249 · Cited by 71
Self-citationBoily, M., Mâsse, B. R., Alsallaq, R. A., PADIAN, N. S., Eaton, J. W., Vesga, J. F., & Hallett, T. B. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001250 · Cited by 69
Self-citationShould we try to eliminate HIV epidemics by using a ‘Test and Treat’ strategy?
Wagner, B. G., Kahn, J. S., & Blower, S. M. (2010) · AIDS · doi:10.1097/qad.0b013e3283366782 · Cited by 69
Venkatesh, K. K., Flanigan, T., & Mayer, K. H. (2011) · AIDS · doi:10.1097/qad.0b013e32834b4ced · Cited by 65
HIV Treatment as Prevention: The Utility and Limitations of Ecological Observation
Smith, M. K., Powers, K. A., Muessig, K. E., Miller, W. C., & Cohen, M. S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001260 · Cited by 65
Venkatesh, K. K., de Bruyn, G., Lurie, M. N., Mohapi, L., Pronyk, P., Moshabela, M., Marinda, E. T., Gray, G., Triche, E. W., & Martinson, N. A. (2010) · AIDS · doi:10.1097/qad.0b013e32833e78d4 · Cited by 63
McCormick, A. W., Walensky, R. P., Lipsitch, M., Losina, E., Hsu, H., Weinstein, M. C., Paltiel, A. D., Freedberg, K. A., & Seage, G. R. (2007) · Clinical Infectious Diseases · doi:10.1086/512816 · Cited by 52
McClelland, R. S., Graham, S. M., Richardson, B. A., Peshu, N., Masese, L. N., Wanje, G., Mandaliya, K. N., Kurth, A., Jaoko, W. G., & Ndinya‐Achola, J. O. (2010) · AIDS · doi:10.1097/qad.0b013e32833616c7 · Cited by 51
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.472 · Cited by 50
Hontelez, J. A. C., Nagelkerke, N. J. D., Bärnighausen, T., Bakker, R., Tanser, F. C., Newell, M., Lurie, M. N., Baltussen, R. M. P. M., & de Vlas, S. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.059 · Cited by 37
Self-citationEvaluating the impact of antiretroviral therapy on HIV transmission
Salomon, J. A., & Hogan, D. R. (2008) · AIDS · doi:10.1097/01.aids.0000327636.82542.87 · Cited by 28
Self-citationEstimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy
Stover, J., Bollinger, L. A., & Ávila, C. (2010) · AIDS Research and Treatment · doi:10.1155/2011/738271 · Cited by 24
Self-citationWagner, B. G., & Blower, S. M. (2009) · Nature Precedings · doi:10.1038/npre.2009.3917.1 · Cited by 19
Cited by
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities
Kharsany, A. B. M., & Karim, Q. A. (2016) · The Open AIDS Journal · doi:10.2174/1874613601610010034 · Cited by 980
Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M.-L. (2013) · Science · doi:10.1126/science.1228160 · Cited by 796
Self-citationIncreases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment
Bor, J., Herbst, A. J., Newell, M.-L., & Bärnighausen, T. (2013) · Science · doi:10.1126/science.1230413 · Cited by 578
Self-citationHuman Immunodeficiency Virus Transmission at Each Step of the Care Continuum in the United States
Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., Fagan, J. L., Lansky, A., & Mermin, J. H. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8180 · Cited by 550
Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)
Hayes, R. J., Donnell, D., Floyd, S., Mandla, N., Bwalya, J., Sabapathy, K., Yang, B., Phiri, M., Schaap, A., Eshleman, S. H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814556 · Cited by 337
Self-citation
Metadata
- Authors
- Eaton, J. W., Johnson, L. F., Salomon, J. A., Bärnighausen, T., Bendavid, E., Bershteyn, A., Bloom, D. E., Cambiano, V., Fraser, C., Hontelez, J. A. C., Humair, S., Klein, D. J., Long, E. F., Phillips, A. N., Pretorius, C., Stover, J., Wenger, E. A., Williams, B. G., & Hallett, T. B.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-10
- Volume
- 9
- Issue
- 7
- Pages
- e1001245
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2131295062
- Cited by
- 395
- References
- 69
- FWCI
- 28.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.